A phase I study of subcutaneously administered aflibercept (VEGF trap) in a new formulation in patients with advanced solid tumors

Overview of attention for article published in Investigational New Drugs, October 2011

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 1 X user
patent: 23 patents

reddit: 1 Redditor

Readers on

mendeley: 29 Mendeley

So far, Altmetric has seen 23 patents that reference this research output.

Methods for treating angiogenic eye disorders with high doses of VEGF receptor fusion…

Grant US-12168036-B2

United States of America

17 Dec 2024

VEGF traps and mini-traps and methods for treating ocular disorders and cancer

Grant US-12103960-B2

United States of America

01 Oct 2024

Anti-VEGF protein compositions and methods for producing the same

Grant US-12077570-B2

United States of America

03 Sep 2024

Anti-VEGF protein compositions and methods for producing the same

Grant US-12054532-B2

United States of America

06 Aug 2024

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 19 additional patents.